Skip to main content

Advertisement

Log in

Radioactive Seed Localization Compared to Wire Localization in Breast-Conserving Surgery: Initial 6-Month Experience

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Wire localization (WL) of nonpalpable breast cancers on the day of surgery is uncomfortable for patients and impacts operating room efficiency. Radioactive seed localization (RSL) before the day of surgery avoids these disadvantages. In this study we compare outcomes of our initial 6-month experience with RSL to those with WL in the preceding 6 months.

Methods

Lumpectomies for invasive or intraductal cancers localized with a single 125iodine seed (January–June 2012) were compared with those using 1 wire (July–December 2011). Surgeons and radiologists did not change. Positive and close margins were defined as tumor on ink and tumor ≤1 mm from ink, respectively. Demographic and clinical characteristics and outcomes were compared between RSL and WL patients.

Results

There were 431 RSL and 256 WL lumpectomies performed. Clinicopathologic characteristics did not differ between groups. Most seeds (90 %) were placed before the day of surgery. Positive margins were present in 7.7 % of RSL versus 5.5 % of WL patients, and 16.9 % of RSL versus 19.9 % of WL had close margins (p = 0.38). The median operative time was longer for lumpectomy and sentinel lymph node biopsy (SLNB) in the RSL group (55 vs. 48 min, p < 0.0001). There was no significant difference in the volume of tissue excised between groups.

Conclusions

In the first 6 months of RSL, operative scheduling was simplified, while rates of positive and close margins were similar to those seen after many years of experience with WL. Operative time was slightly longer for RSL lumpectomy and SLNB; we anticipate this will decrease with experience.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lovrics PJ, Goldsmith CH, Hodgson N, McCready D, Gohla G, Boylan C, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol. 2011;18:3407–14.

    Article  PubMed  Google Scholar 

  2. Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg. 2004;91:1575–7.

    Article  PubMed  CAS  Google Scholar 

  3. Arentz C, Baxter K, Boneti C, Henry-Tillman R, Westbrook K, Korourian S, et al. Ten-year experience with hematoma-directed ultrasound-guided (HUG) breast lumpectomy. Ann Surg Oncol. 2010;17 Suppl 3:378–83.

    Article  PubMed  Google Scholar 

  4. Klein RL, Mook JA, Euhus DM, Rao R, Wynn RT, Eastman AB, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK(R)) as an alternative to wire and radioactive seed localization for non-palpable breast lesions. J Surg Oncol. 2012;105:591–4.

    Article  PubMed  CAS  Google Scholar 

  5. Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007;14:2928–31.

    Article  PubMed  Google Scholar 

  6. Lavoue V, Nos C, Clough KB, Baghaie F, Zerbib E, Poulet B, et al. Simplified technique of radioguided occult lesion localization (ROLL) plus sentinel lymph node biopsy (SNOLL) in breast carcinoma. Ann Surg Oncol. 2008;15:2556–61.

    Article  PubMed  Google Scholar 

  7. Alderliesten T, Loo CE, Pengel KE, Rutgers EJ, Gilhuijs KG, Vrancken Peeters MJ. Radioactive seed localization of breast lesions: an adequate localization method without seed migration. Breast J. 2011;17:594–601.

    Article  PubMed  Google Scholar 

  8. van Riet YE, Maaskant AJ, Creemers GJ, van Warmerdam LJ, Jansen FH, van de Velde CJ, et al. Identification of residual breast tumour localization after neo-adjuvant chemotherapy using a radioactive 125 Iodine seed. Eur J Surg Oncol. 2010;36:164–9.

    Article  PubMed  Google Scholar 

  9. McGhan LJ, McKeever SC, Pockaj BA, Wasif N, Giurescu ME, Walton HA, et al. Radioactive seed localization for nonpalpable breast lesions: review of 1,000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18:3096–101.

    Article  PubMed  Google Scholar 

  10. van Riet YE, Jansen FH, van Beek M, van de Velde CJ, Rutten HJ, Nieuwenhuijzen GA. Localization of non-palpable breast cancer using a radiolabelled titanium seed. Br J Surg. 2010;97:1240–5.

    Article  PubMed  Google Scholar 

  11. Corben AD, Morrow M. Margins in breast cancer surgery. In: El-Tamer MB, editor. Principles and techniques in oncoplastic breast cancer surgery. Singapore: World Scientific Publishing Co., 2012:65–85.

    Chapter  Google Scholar 

  12. Dodd GD, Fry K, Delany W. Preoperative localization of occult carcinoma of the breast. In: Nealton TP, editor. Management of the patient with cancer. Philadelphia: Saunders, 1965:88–113.

    Google Scholar 

  13. Hughes JH, Mason MC, Gray RJ, McLaughlin SA, Degnim AC, Fulmer JT, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 2008;14:153–7.

    Article  PubMed  Google Scholar 

  14. Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188:377–80.

    Article  PubMed  Google Scholar 

  15. Donker M, Drukker CA, Valdes Olmos RA, Rutgers EJ, Loo CE, Sonke GS, et al. Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL technique. Ann Surg Oncol. 2013;20:2569–75.

    Google Scholar 

  16. Sung JS, King V, Thornton CM, Brooks JD, Fry CW, El-Tamer M, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82:1453–7.

    Google Scholar 

  17. Dauer LT, Thornton C, Miodownik D, et al. Radioactive seed localization with iodine-125 for non-1 palpable lesions prior to breast lumpectomy and/or excisional biopsy: methodology, safety and experience of initial year. Health Phys. 2013 (in press).

  18. Pavlicek W, Walton HA, Karstaedt PJ, Gray RJ. Radiation safety with use of I-125 seeds for localization of nonpalpable breast lesions. Acad Radiol. 2006;13:909–15.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was presented in part as a poster at the 2013 Society of Surgical Oncology Annual Cancer Symposium, National Harbor, MD. March 7–9, 2013. This study was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Monica Morrow MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Murphy, J.O., Moo, TA., King, T.A. et al. Radioactive Seed Localization Compared to Wire Localization in Breast-Conserving Surgery: Initial 6-Month Experience. Ann Surg Oncol 20, 4121–4127 (2013). https://doi.org/10.1245/s10434-013-3166-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-013-3166-4

Keywords

Navigation